LyTONEPAL: long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: a French population-based cohort

Debillon, Thierry; Bednarek, Nathalie; Ego, Anne; Baud, Olivier; LyTONEPAL Writing Group

doi:10.1186/s12887-018-1232-6

Scientific article

English

LyTONEPAL: long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: a French population-based cohort

ContributorsDebillon, Thierry; Bednarek, Nathalie; Ego, Anne; Baud, Olivier; LyTONEPAL Writing Group

Published inBMC Pediatrics, vol. 18, no. 1, 255

Publication date2018

Abstract

Hypoxic-ischemic encephalopathy (HIE) is a rare neonatal condition affecting about 1‰ births. Despite a significant improvement in the management of this condition in the last ten years, HIE remains associated with high rates of death and severe neurological disability. From September 2015 to March 2017, a French national cohort of HIE cases was conducted to estimate the extent of long-term moderate and severe neurodevelopmental disability at 3 years and its determinants.

Keywords

Cohort
Hypoxic ischemic encephalopathy
Late preterm and term births
Population-based study
Therapeutic hypothermia

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Research groups

Prévention des complications néonatales d'origine périnatale (990)

Citation (ISO format)

DEBILLON, Thierry et al. LyTONEPAL: long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: a French population-based cohort. In: BMC Pediatrics, 2018, vol. 18, n° 1, p. 255. doi: 10.1186/s12887-018-1232-6